Directory of Stock Market Company
This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.
Search into NYSE and TSX
by quote, company name or key word
ABT - Abbott Laboratories
Abbott Laboratories (Abbott), incorporated in 1900, is engaged in discovery, development, manufacture, and sale of a diversified line of healthcare products. The Company operates in four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Pharmaceutical Products include a line of adult and pediatric pharmaceuticals manufactured, marketed, and sold","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"
Abbott Laboratories News
J&J's Simponi Helps Colitis Patients In Clinical Trial
Wall Street Journal - 8 hours ago
Wall Street Journal - 8 hours ago
By Peter Loftus Of DOW JONES NEWSWIRES Johnson & Johnson (JNJ) said its drug Simponi improved symptoms in a majority of patients with an inflammatory-bowel disease in a new clinical trial.
How does pharma's CEO pay rank?
FiercePharma - 12 hours ago
FiercePharma - 12 hours ago
We know how pharma CEO pay stacked up within the industry. But how did pharma's 2011 compensation packages compare with those in other industries?
Pfizer (NYSE:PFE) Xalkori Ends Sings of Deadly Child Cancers in Trail – PFE ...
PT News - 14 hours ago
PT News - 14 hours ago
Pfizer Inc's (NYSE:PFE) Xalkori, a medicine that targets lung cancer rooted by a gene defect, destroyed entire indications of malignancy in several children with different cancer types, in a trail that confirms aiming action at genes before disease ...
Pfizer (NYSE:PFE) Cancers Drug Xalkori Stops Deadly Kids Tumor –PFE, MRK, ABT, BMY
PT News - 15 hours ago
PT News - 15 hours ago
Pfizer Inc (NYSE:PFE) reported that its drug that has distorted treatment for adult lung cancers sourced by a gene fault is currently saving children with deadly cancers.
Healthcare Giant Pfizer (NYSE:PFE) Recalls 650000 Units of Advil Liqui-Gels ... - eStocksDaily
Abbott Laboratories (NYSE:ABT) shares were trading at $61.57 while reporting ...
The Mumbai Times - 16 hours ago
The Mumbai Times - 16 hours ago
The 16 analysts offering 12-month price forecasts for Abbott Laboratories have a median target of 65.00, with a high estimate of 80.00 and a low estimate of 55.00.
Medgenics Moving In Record Time - Seeking Alpha
Notable ETF Inflow Detected - SSO, ABT, ANF, ACN
Forbes - May 17, 2012
Forbes - May 17, 2012
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Proshares Ultra S&P500 (AMEX: SSO) where we have detected an approximate $54.3 million dollar inflow - that's a 4.6% ...
Abbott Laboratories launches PediaSure SideKicks Clear for picky eaters
RTT News - May 16, 2012
RTT News - May 16, 2012
(RTTNews) - Abbott Laboratories (ABT: News ) Wednesday announced that it has introduced PediaSure SideKicks Clear, a refreshing clear nutritional beverage that helps balance out the diet of those picky eaters who are growing fine, but still may be ...
ABBOTT LABORATORIES : Abbott Launches PediaSure SideKicks ® Clear for Picky Eaters - 4-traders
Today's Hot Stocks: Sodastream International, Petroleo Brasileiro SA, Newmont ...
MarketWatch (press release) - May 10, 2012
MarketWatch (press release) - May 10, 2012
VANCOUVER, British Columbia, May 10, 2012 /PRNewswire via COMTEX/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Sodastream International (NASDAQ:SODA) , Petroleo Brasileiro SA ...
Abbott: New Reasons The Split Could Tank Stock
Seeking Alpha - May 8, 2012
Seeking Alpha - May 8, 2012
Abbott Laboratories (ABT) has announced that it will split in two by the end of 2012. One half will be a diversified medical products company, while the other will be a research-based pharmaceutical companies.
Our View: Abbott Laboratories (NYSE:ABT) Makes Second-Biggest Settlement in US ...
The Mumbai Times - May 8, 2012
The Mumbai Times - May 8, 2012
Merck & Co Inc (NYSE:MRK) shares were trading at $4:00pm ET, 05/07/2012 while reporting down 0.77% from yesterdays close. The 17 analysts offering 12-month price forecasts for Merck & Co Inc have a median target of 42.00, with a high estimate of 46.00 ...
NYSE Media Coverage Selection of the best articles found in your favorit medias